 CINCINNATI , May 23, 2022 PRNewswire -- Meridian Bioscience, Inc. NASDAQ: VIVO, a leading global provider of diagnostic testing solutions and life science raw materials, announced today its participation in the 2022 H.C. Wainwright Global Investment Conference. 